SFS
LFCR icon

Sowell Financial Services’s Lifecore Biomedical LFCR Stock Holding History

Sowell Financial Services’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,220
Closed -$40K – 1746
2021
Q1 		$40K Buy
3,220
+975
+43% +$11K ﹤0.01% 1746
2020
Q4 		$24K Buy
2,245
+46
+2% +$475 ﹤0.01% 1657
2020
Q3 		$21K Buy
2,199
+339
+18% +$3.23K ﹤0.01% 1543
2020
Q2 		$15K Buy
1,860
+128
+7% +$1.32K ﹤0.01% 1551
2020
Q1 		$15K Buy
1,732
+668
+63% +$6.95K ﹤0.01% 1481
2019
Q4 		$12K Hold
1,064
– – ﹤0.01% 1627
2019
Q3 		$12K Buy
+1,064
New +$11.6K ﹤0.01% 1473

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Sowell Financial Services's LFCR Position: Q2 2021 in Review

Sowell Financial Services sold out of Lifecore Biomedical (LFCR) in Q2 2021, closing a stake of 3,220 shares — an estimated $40K sold.

Sowell Financial Services first reported a position in LFCR in Q3 2019 and held it in 7 quarters. The position peaked at $40K in Q1 2021. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2021.

  • Sowell Financial Services reported no remaining Lifecore Biomedical position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 3,220 Lifecore Biomedical shares in Q2 2021, an estimated $40K.
  • Sowell Financial Services first reported a position in Lifecore Biomedical in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Lifecore Biomedical position peaked at $40K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.